ATOSSA THERAPEUTICS INC. - COMMON STOCK
0.9441
31-十二月-24 15:45:00
15 分钟延时
股票
-0.0300
-3.08%
今日范围
0.9130 - 1.0000
ISIN
N/A
来源
NASDAQ
-
11 12月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
10 12月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
09 12月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research
21 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
20 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
12 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
05 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
04 11月 2024 05:30:00 条件 Nasdaq GlobeNewswire
-
31 10月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
21 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit
14 10月 2024 16:08:43 条件 Nasdaq GlobeNewswire
-
01 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
28 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
21 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
20 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
12 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >